1
|
Ashley RJ, Yan H, Wang N, Hale J, Dulmovits BM, Papoin J, Olive ME, Udeshi ND, Carr SA, Vlachos A, Lipton JM, Da Costa L, Hillyer C, Kinet S, Taylor N, Mohandas N, Narla A, Blanc L. Steroid resistance in Diamond Blackfan anemia associates with p57Kip2 dysregulation in erythroid progenitors. J Clin Invest 2020; 130:2097-2110. [PMID: 31961825 DOI: 10.1172/jci132284] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2019] [Accepted: 01/14/2020] [Indexed: 12/14/2022] Open
Abstract
Despite the effective clinical use of steroids for the treatment of Diamond Blackfan anemia (DBA), the mechanisms through which glucocorticoids regulate human erythropoiesis remain poorly understood. We report that the sensitivity of erythroid differentiation to dexamethasone is dependent on the developmental origin of human CD34+ progenitor cells, specifically increasing the expansion of CD34+ progenitors from peripheral blood (PB) but not cord blood (CB). Dexamethasone treatment of erythroid-differentiated PB, but not CB, CD34+ progenitors resulted in the expansion of a newly defined CD34+CD36+CD71hiCD105med immature colony-forming unit-erythroid (CFU-E) population. Furthermore, proteomics analyses revealed the induction of distinct proteins in dexamethasone-treated PB and CB erythroid progenitors. Dexamethasone treatment of PB progenitors resulted in the specific upregulation of p57Kip2, a Cip/Kip cyclin-dependent kinase inhibitor, and we identified this induction as critical; shRNA-mediated downregulation of p57Kip2, but not the related p27Kip1, significantly attenuated the impact of dexamethasone on erythroid differentiation and inhibited the expansion of the immature CFU-E subset. Notably, in the context of DBA, we found that steroid resistance was associated with dysregulated p57Kip2 expression. Altogether, these data identify a unique glucocorticoid-responsive human erythroid progenitor and provide new insights into glucocorticoid-based therapeutic strategies for the treatment of patients with DBA.
Collapse
Affiliation(s)
- Ryan J Ashley
- Department of Molecular Medicine and Pediatrics, Donald and Barbara Zucker School of Medicine, Hofstra/Northwell, Hempstead, New York, USA.,Center for Autoimmunity, Musculoskeletal and Hematopoietic Diseases, The Feinstein Institutes for Medical Research, Manhasset, New York, USA
| | - Hongxia Yan
- Red Cell Physiology Laboratory, New York Blood Center, New York, New York, USA.,Institut de Génétique Moléculaire de Montpellier, University of Montpellier, Montpellier, France
| | - Nan Wang
- Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA
| | - John Hale
- Red Cell Physiology Laboratory, New York Blood Center, New York, New York, USA
| | - Brian M Dulmovits
- Department of Molecular Medicine and Pediatrics, Donald and Barbara Zucker School of Medicine, Hofstra/Northwell, Hempstead, New York, USA.,Center for Autoimmunity, Musculoskeletal and Hematopoietic Diseases, The Feinstein Institutes for Medical Research, Manhasset, New York, USA
| | - Julien Papoin
- Center for Autoimmunity, Musculoskeletal and Hematopoietic Diseases, The Feinstein Institutes for Medical Research, Manhasset, New York, USA
| | - Meagan E Olive
- Proteomics Platform, Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA
| | - Namrata D Udeshi
- Proteomics Platform, Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA
| | - Steven A Carr
- Proteomics Platform, Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA
| | - Adrianna Vlachos
- Department of Molecular Medicine and Pediatrics, Donald and Barbara Zucker School of Medicine, Hofstra/Northwell, Hempstead, New York, USA.,Center for Autoimmunity, Musculoskeletal and Hematopoietic Diseases, The Feinstein Institutes for Medical Research, Manhasset, New York, USA.,Pediatric Hematology/Oncology, Cohen Children's Medical Center, New Hyde Park, New York, USA
| | - Jeffrey M Lipton
- Department of Molecular Medicine and Pediatrics, Donald and Barbara Zucker School of Medicine, Hofstra/Northwell, Hempstead, New York, USA.,Center for Autoimmunity, Musculoskeletal and Hematopoietic Diseases, The Feinstein Institutes for Medical Research, Manhasset, New York, USA.,Pediatric Hematology/Oncology, Cohen Children's Medical Center, New Hyde Park, New York, USA
| | | | - Christopher Hillyer
- Red Cell Physiology Laboratory, New York Blood Center, New York, New York, USA
| | - Sandrina Kinet
- Institut de Génétique Moléculaire de Montpellier, University of Montpellier, Montpellier, France
| | - Naomi Taylor
- Institut de Génétique Moléculaire de Montpellier, University of Montpellier, Montpellier, France.,Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA
| | - Narla Mohandas
- Red Cell Physiology Laboratory, New York Blood Center, New York, New York, USA
| | - Anupama Narla
- Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA
| | - Lionel Blanc
- Department of Molecular Medicine and Pediatrics, Donald and Barbara Zucker School of Medicine, Hofstra/Northwell, Hempstead, New York, USA.,Center for Autoimmunity, Musculoskeletal and Hematopoietic Diseases, The Feinstein Institutes for Medical Research, Manhasset, New York, USA.,Pediatric Hematology/Oncology, Cohen Children's Medical Center, New Hyde Park, New York, USA
| |
Collapse
|
2
|
Jiang S, Hillyer C, Du L. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355-359; 2020). Trends Immunol 2020; 41:545. [PMID: 32362491 PMCID: PMC7271084 DOI: 10.1016/j.it.2020.04.008] [Citation(s) in RCA: 98] [Impact Index Per Article: 24.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
|
3
|
Abstract
Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs.
Collapse
Affiliation(s)
- Shibo Jiang
- Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai, China
| | - Christopher Hillyer
- Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA
| | - Lanying Du
- Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA.
| |
Collapse
|
4
|
Yan H, Hale J, Jaffray J, Li J, Wang Y, Huang Y, An X, Hillyer C, Wang N, Kinet S, Taylor N, Mohandas N, Narla A, Blanc L. Developmental differences between neonatal and adult human erythropoiesis. Am J Hematol 2018; 93:494-503. [PMID: 29274096 DOI: 10.1002/ajh.25015] [Citation(s) in RCA: 41] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2017] [Accepted: 12/20/2017] [Indexed: 02/04/2023]
Abstract
Studies of human erythropoiesis have relied, for the most part, on the in vitro differentiation of hematopoietic stem and progenitor cells (HSPC) from different sources. Here, we report that despite the common core erythroid program that exists between cord blood (CB)- and peripheral blood (PB)-HSPC induced toward erythroid differentiation in vitro, significant functional differences exist. We undertook a comparative analysis of human erythropoiesis using these two different sources of HSPC. Upon in vitro erythroid differentiation, CB-derived cells proliferated 4-fold more than PB-derived cells. However, CB-derived cells exhibited a delayed kinetics of differentiation, resulting in an increased number of progenitors, notably colony-forming unit (CFU-E). The phenotypes of early erythroid differentiation stages also differed between the two sources with a significantly higher percentage of IL3R- GPA- CD34+ CD36+ cells generated from PB- than CB-HSPCs. This subset was found to generate both burst-forming unit (BFU-E) and CFU-E colonies in colony-forming assays. To further understand the differences between CB- and PB-HSPC, cells at eight stages of erythroid differentiation were sorted from each of the two sources and their transcriptional profiles were compared. We document differences at the CD34, BFU-E, poly- and orthochromatic stages. Genes exhibiting the most significant differences in expression between HSPC sources clustered into cell cycle- and autophagy-related pathways. Altogether, our studies provide a qualitative and quantitative comparative analysis of human erythropoiesis, highlighting the impact of the developmental origin of HSPCs on erythroid differentiation.
Collapse
Affiliation(s)
- Hongxia Yan
- Red Cell Physiology Laboratory; New York Blood Center; New York New York 10065
| | - John Hale
- Red Cell Physiology Laboratory; New York Blood Center; New York New York 10065
| | - Julie Jaffray
- Red Cell Physiology Laboratory; New York Blood Center; New York New York 10065
| | - Jie Li
- Membrane Biology Laboratory; New York Blood Center; New York New York 10065
| | - Yaomei Wang
- Membrane Biology Laboratory; New York Blood Center; New York New York 10065
| | - Yumin Huang
- Membrane Biology Laboratory; New York Blood Center; New York New York 10065
| | - Xiuli An
- Membrane Biology Laboratory; New York Blood Center; New York New York 10065
| | - Christopher Hillyer
- Red Cell Physiology Laboratory; New York Blood Center; New York New York 10065
| | - Nan Wang
- Stanford University School of Medicine; Palo Alto California 94304
| | - Sandrina Kinet
- GREx, Institut de Génétique Moléculaire de Montpellier, University of Montpellier; CNRS Montpellier 34095 France
| | - Naomi Taylor
- GREx, Institut de Génétique Moléculaire de Montpellier, University of Montpellier; CNRS Montpellier 34095 France
| | - Narla Mohandas
- Red Cell Physiology Laboratory; New York Blood Center; New York New York 10065
| | - Anupama Narla
- Stanford University School of Medicine; Palo Alto California 94304
| | - Lionel Blanc
- Laboratory of Developmental Erythropoiesis; Center for Autoimmune, Musculoskeletal, and Hematopoietic Diseases, The Feinstein Institute for Medical Research; Manhasset New York 11030
- Department of Molecular Medicine and Pediatrics, Donald and Barbara Zucker School of Medicine at Hofstra Northwell; Hempstead New York 11549
| |
Collapse
|
5
|
Roth WK, Busch MP, Schuller A, Ismay S, Cheng A, Seed CR, Jungbauer C, Minsk PM, Sondag-Thull D, Wendel S, Levi JE, Fearon M, Delage G, Xie Y, Jukic I, Turek P, Ullum H, Tefanova V, Tilk M, Reimal R, Castren J, Naukkarinen M, Assal A, Jork C, Hourfar MK, Michel P, Offergeld R, Pichl L, Schmidt M, Schottstedt V, Seifried E, Wagner F, Weber-Schehl M, Politis C, Lin CK, Tsoi WC, O'Riordan J, Gottreich A, Shinar E, Yahalom V, Velati C, Satake M, Sanad N, Sisene I, Bon AH, Koppelmann M, Flanagan P, Flesland O, Brojer E, Lętowska M, Nascimento F, Zhiburt E, Chua SS, Teo D, Stezinar SL, Vermeulen M, Reddy R, Park Q, Castro E, Eiras A, Gonzales Fraile I, Torres P, Ekermo B, Niederhauser C, Chen H, Oota S, Brant LJ, Eglin R, Jarvis L, Mohabir L, Brodsky J, Foster G, Jennings C, Notari E, Stramer S, Kessler D, Hillyer C, Kamel H, Katz L, Taylor C, Panzer S, Reesink HW. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang 2011; 102:82-90. [PMID: 21933190 DOI: 10.1111/j.1423-0410.2011.01506.x] [Citation(s) in RCA: 146] [Impact Index Per Article: 11.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
6
|
Rubinstein P, Hillyer C. Histocompatibility and immunogenetics in cord blood transplantation. Biol Res 2010; 43:339-345. [PMID: 21249306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023] Open
Abstract
This review of the immunogenetics of cord blood transplantation attempts to highlight the connections between classical studies and conclusions of the tissue transplantation field as a scholarly endeavor, exemplified by the work of Professor Hoecker, with the motivations and some recent and key results of clinical cord blood transplantation. The authors review the evolution of understanding of transplantation biology and find that the results of the application of cord blood stem cells to Transplantation Medicine are consistent with the careful experiments of the pioneers in the field, from the results of tumor and normal tissue transplants, histocompatibility immunogenetics, to cell and molecular biology. Recent results of the National Cord Blood Program of the New York Blood Center describe the functioning in cord blood transplantation of factors, well known in transplantation immunogenetics, like the Fl anti-parent effect and the tolerance-like status of donors produced by non-inherited maternal HLA antigens. Consideration of these factors in donor selection strategies can improve the prognosis of transplantation by characterizing "permissibility" in HLA-incompatible transplantation thereby increasing the probability of survival and reducing the likelihood of leukemic relapse.
Collapse
Affiliation(s)
- Pablo Rubinstein
- National Cord Blood Program, New York Blood Center, 310 East 67th Street, New York, NY 10065, USA.
| | | |
Collapse
|
7
|
Rubinstein P, Hillyer C. Histocompatibility and Immunogenetics in Cord Blood Transplantation. Biol Res 2010. [DOI: 10.4067/s0716-97602010000300011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
8
|
Mintz PD, Neff A, MacKenzie M, Goodnough LT, Hillyer C, Kessler C, McCrae K, Menitove JE, Skikne BS, Damon L, Lopez-Plaza I, Rouault C, Crookston KP, Benjamin RJ, George J, Lin JS, Corash L, Conlan MG. A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura. Transfusion 2006; 46:1693-704. [PMID: 17002625 DOI: 10.1111/j.1537-2995.2006.00959.x] [Citation(s) in RCA: 85] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
BACKGROUND Photochemical treatment of fresh-frozen plasma (FFP) with amotosalen and ultraviolet (UV) A light (PCT FFP) results in inactivation of a broad spectrum of pathogens while retaining coagulation factor activity, antithrombotic proteins, and von Willebrand factor-cleaving protease (VWF-CP) activity. STUDY DESIGN AND METHODS A randomized, controlled, double-blind Phase III trial was conducted with PCT FFP or control FFP for therapeutic plasma exchange (TPE) in patients with thrombotic thrombocytopenic purpura (TTP). Owing to the rarity of this diagnosis, the trial was not powered to demonstrate small differences between treatment groups. Patients were treated with study FFP for a maximum of 35 days until remission was achieved (for a maximum of 30 daily study TPEs with no remission) plus an additional 5 days after remission. RESULTS Among the 35 patients treated, the primary endpoint, remission within 30 days, was achieved by 14 of 17 (82%) PCT patients and 16 of 18 (89%) control patients (p = 0.658) The 90 percent confidence interval for treatment difference in remission rate for test - control was (-0.291 to 0.163). Time to remission, relapse rates, time to relapse, total volume and number of FFP units exchanged, and number of study TPEs were not significantly different between groups. Improvement in VWF-CP and inhibitors was similar for both groups. The overall safety profile of PCT FFP was similar to control FFP. No antibodies to amotosalen neoantigens were detected. CONCLUSION The comparable results between treatment groups observed from this small trial suggest that TPE with PCT FFP was safe and effective for treatment of TTP.
Collapse
Affiliation(s)
- Paul D Mintz
- University of Virginia Health System, Charlottesville, Virginia, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Hillyer C, Dzik S, Goldman M. Journal club. Transfus Med Rev 2003. [DOI: 10.1016/j.tmrv.2003.09.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
10
|
Dzik S, Goldman M, Hillyer C. Journal club. Transfus Med Rev 2003. [DOI: 10.1016/s0887-7963(03)00024-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
11
|
Goldman M, Hillyer C, Dzik S. Journal club. Transfus Med Rev 2003. [DOI: 10.1016/s0887-7963(03)70001-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
12
|
Goldman M, Hillyer C, Dzik S. Journal club. Transfus Med Rev 2003. [DOI: 10.1053/tmrv.2003.50010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
13
|
Nightingale S, Wanamaker V, Silverman B, McCurdy P, McMurtry L, Quarles P, Sandler SG, Triulzi D, Whitsett C, Hillyer C, McCarthy L, Goldfinger D, Satcher D. Use of sentinel sites for daily monitoring of the US blood supply. Transfusion 2003; 43:364-72. [PMID: 12675723 DOI: 10.1046/j.1537-2995.2003.00324.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
BACKGROUND This report describes the first year of a government-sponsored program that uses daily reports from 29 sentinel sites to monitor the capacity of the US blood supply to meet demand. STUDY DESIGN AND METHODS From August 15, 2001, to August 14, 2002, 29 sentinel sites provided daily reports of the number of units of RBCs in inventory, transfused, exported, and outdated by ABO and Rh, and platelets by random or apheresis donor. Days supply of each component category was calculated as the number of units in inventory reported on a day divided by the sum of units transfused, exported, and outdated on that day. Sites also provided daily responses to questions about threatened or actual shortages. RESULTS The median of the days supply of RBCs at the 26 hospital transfusion services was 7.2 days. However, median days supply varied substantially by site and by day of the week. A+, O+, and O- units accounted for 30, 35, and 12 percent of total inventory and were maintained at a median supply of 7.4, 6.4, and 9.5 days, respectively. Reports of threatened RBC shortages peaked in early January 2002 and again in early July 2002. The July 2002 peak was about twice the January 2002 peak. Inventories at community-based centers were similar to those at hospital transfusion services. Hospitals maintained only a 1-day supply of platelets. Eight percent of random and 4 percent of apheresis platelets were outdated. There were 20 reports that surgery had to be postponed or canceled because platelets were unavailable. CONCLUSIONS Inventories of RBCs maintained at the participating sites were sufficient, with only one brief exception, to meet local demand during the first year of this monitoring program. The weekly rate of threatened shortage reports was more sensitive than days inventory as a predictor of actual shortages of RBCs. Unlike RBCs, platelet days supply, reports of threatened or actual platelet shortages, and platelet outdate rates did not vary seasonally.
Collapse
Affiliation(s)
- Stephen Nightingale
- Office of Public Health and Science, Department of Health and Human Services, Washington, DC, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Hillyer C. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietinN. Casadevall, J. Nataf, B. Viron, et al. N Engl J Med 346:469–475, 2002. Transfus Med Rev 2003. [DOI: 10.1053/s0887-7963(03)80008-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
15
|
Hillyer C. Increased rate of infection associated with transfusion of old blood after severe injuryP.J. Offner, E.E. Moore, W.L. Biffl, et al. Arch Surg 137:711–717, 2002. Transfus Med Rev 2003. [DOI: 10.1053/s0887-7963(03)80009-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
16
|
Hillyer C. Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: Severely deficient activity is specific for thrombotic thrombocytopenic purpuraV. Bianchi, R. Robles, L. Alberio, et al. Blood 100:710–713, 2002. Transfus Med Rev 2003. [DOI: 10.1053/s0887-7963(03)80011-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
17
|
Hillyer C. Cefotetan-induced hemolytic anemia: A review of 85 casesR. Viraraghavan, A.G. Chakravarty, J. Soreth. Adverse Drug React Toxicol Rev 21:101–107, 2002. Transfus Med Rev 2003. [DOI: 10.1053/s0887-7963(03)80012-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
18
|
Hillyer C. Isoimmunization is unlikely to be the cause of hemolysis in ABO-incompatible but direct antiglobulin testnegative neonatesM. Herschel, T. Karrison, M. Wen, et al. Pediatrics 110:127–130, 2002. Transfus Med Rev 2003. [DOI: 10.1053/s0887-7963(03)80010-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
19
|
Hillyer C. Longitudinal changes in ferritin during chronic transfusion: A report from the stroke prevention trial in sickle cell Anemia (STOP)B. Files, D. Brambilla, A. Kutlar, et al. J Ped Hematol Oncol 24:284–289, 2002. Transfus Med Rev 2003. [DOI: 10.1053/s0887-7963(03)80007-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
20
|
Hillyer C. Lead levels in blood bank bloodS. Bulleova, S. J. Rothenberg, M. Manalo. Arch Environ Health 56:4312–4313 2001. Transfus Med Rev 2002. [DOI: 10.1053/s0887-7963(02)80139-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
21
|
Hillyer C. The role of transfusion-transmitted virus in patients undergoing hemodialysisR. Valtuille, F. Frankel, F. Gomez, H. et al. J Clin Gastroenterol 34:86–88, 2002. Transfus Med Rev 2002. [DOI: 10.1053/s0887-7963(02)80143-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
22
|
Hillyer C. Quality indicators of blood utilization: Three College of American Pathologists Q-Probes studies of 12 288 404 red blood cell units in 1639 hospitalsD.A. Novis, S. Renner, R. Friedberg, et al. Arch Pathol Lab Med 126:150–156, 2002. Transfus Med Rev 2002. [DOI: 10.1053/s0887-7963(02)80145-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
23
|
Hillyer C. Blood transfusions in elderly patients with acute myocardial infarctionW. Wu, S. Rathore, Y. Wang, et al. N Engl J Med 345:1230–1236, 2001. Transfus Med Rev 2002. [DOI: 10.1053/s0887-7963(02)80141-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
24
|
Hillyer C. The dynamic of hepatitis C virus binding to platelets and 2 mononuclear cell linesS. Harmaia, C. Li, J.P. Allain. Blood 98:2293–2300, 2001. Transfus Med Rev 2002. [DOI: 10.1053/s0887-7963(02)80140-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
25
|
Hillyer C. Adoptive transfer of simian immunodeficiency virus (SIV) naive autologous CD4+ cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor statusF. Villinger, G.T. Brice, A.E. Mayne, et al. Blood 99:590–99, 2002. Transfus Med Rev 2002. [DOI: 10.1053/s0887-7963(02)80144-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
26
|
Hillyer C. Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantationJ. Teruya, M. Styler, S. Verde, et al. J Clin Aphresis 16:169–174, 2001. Transfus Med Rev 2002. [DOI: 10.1053/s0887-7963(02)80142-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
27
|
Hillyer C. HIV transmissions From a window-period platelet donation. Transfus Med Rev 2002. [DOI: 10.1016/s0887-7963(02)80067-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
28
|
Hillyer C. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparumM. Surolia, A. Surolia. Nat Med 7:167–173, 2001. Transfus Med Rev 2002. [DOI: 10.1053/tmrv.2002.31458] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
29
|
Hillyer C. Residual risk of transfusion in GhanaD. Candotti, F. Sarkodie, J. Allain. Br J haematol 113:37–39, 2001. Transfus Med Rev 2002. [DOI: 10.1053/s0887-7963(02)80050-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
30
|
Hillyer C. Rheumatoid arthritis and hepatitis B virus: Evaluating the pathogenic linkA. Csepregi, E. Nemesanszky, B. Rojkovic, et al. Rheumatol 28:474–477, 2001. Transfus Med Rev 2002. [DOI: 10.1053/s0887-7963(02)80049-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
31
|
Hillyer C. Intrauterine transmission of cytomegalovirus to infants of women with preconceptual immunityS. Boppana, L. Rivera, K. Fowler, et al. N Engl J Med 344: 1366–1371, 2001. Transfus Med Rev 2002. [DOI: 10.1053/s0887-7963(02)80046-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
32
|
Hillyer C. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpuraG. Levy, W. Nichols, E. Lian, et al. Nature 413:488–494, 2001. Transfus Med Rev 2002. [DOI: 10.1053/s0887-7963(02)80048-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
33
|
Hillyer C. Infection with GB virus C and reduced mortality among HIV-infected patientsH.L. Tillman, H. Heiken, A. Knapik-Botor, et al. N Engl J Med 345:715–724, 2001. Transfus Med Rev 2002. [DOI: 10.1053/s0887-7963(02)80036-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
34
|
Hillyer C. Platelet transfusion for patients with cancer: Clinical practice guidelines of the American society of clinical oncologyC.A. Schiffer, K.C. Anderson, C.L. Bennett, et al. J Clin Oncol 19:1519–1538, 2001. Transfus Med Rev 2002. [DOI: 10.1053/s0887-7963(02)80051-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
35
|
Hillyer C. Effect of coinfection with GB virus C on survival among patients with HIV infectionJ. Xiang, S. Wünschmann, D. J. Diekema, et al. N Engl J Med 345:707–714, 2001. Transfus Med Rev 2002. [DOI: 10.1053/s0887-7963(02)80047-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
36
|
Hillyer C. Morbidity and mortality in adults with idiopathic thrombocytopenic purpuraJ.F.A. Portielje, R.G.I. Westendorp, H.C. Kluin-Nelemans, et al. Blood 97: 2549–2554, 2001. Transfus Med Rev 2002. [DOI: 10.1016/s0887-7963(02)80022-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
37
|
Hillyer C. Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994–2000S. Cousens, P.G. Smith, H. Ward, et al. Lancet 357:1002–1007, 2001. Transfus Med Rev 2002. [DOI: 10.1016/s0887-7963(02)80020-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
38
|
Hillyer C. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donorsM.I. Laughlin, J. Barker, B. Bambach, et al. N Engl J Med 344:1815–1821, 2001. Transfus Med Rev 2002. [DOI: 10.1016/s0887-7963(02)80024-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
39
|
Hillyer C. A randomized controlled trial of transfusion-related lung injury: Is plasma from multiparous blood donors dangerous?M. Palfi, S. Berg, J. Ernerudh, et al. Transfusion 41:317–322, 2001. Transfus Med Rev 2002. [DOI: 10.1016/s0887-7963(02)80021-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
40
|
Hillyer C. Plasminogen binds to disease-associated prion protein of multiple speciesM. Maissen, C. Roeckl, M. Glatzel, et al. Lancet 357:2026–2028, 2001. Transfus Med Rev 2002. [DOI: 10.1016/s0887-7963(02)80025-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
41
|
Hillyer C. Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modalityH. Hebart, W. Brugger, U. Grigoleit, et al. Blood 97:2183–2185, 2001. Transfus Med Rev 2001. [DOI: 10.1053/s0887-7963(01)80087-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
42
|
Hillyer C. A novel erythroid-specific marker of transmissible spongiform encephalopathiesG. Miele, J. Manson, M. Clinton. Nat Med 7:361–364, 2001. Transfus Med Rev 2001. [DOI: 10.1053/tmrv.2001.26961] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
43
|
Hillyer C. Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence. Transfus Med Rev 2001. [DOI: 10.1016/s0887-7963(01)80091-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
44
|
Hillyer C. Postgrafting administration of granulocyte colony-stimulating factor imparis functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplantsI. Volpi, K. Perruccio, A. Tosti, et al. Blood 97:2514–2521, 2000. Transfus Med Rev 2001. [DOI: 10.1053/s0887-7963(01)80086-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
45
|
Hillyer C. The effect of blood transfusion protocol on retinopathy of prematurity: A prospective, randomized study. Transfus Med Rev 2001. [DOI: 10.1016/s0887-7963(01)80068-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
46
|
Hillyer C. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Transfus Med Rev 2001. [DOI: 10.1016/s0887-7963(01)80066-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
47
|
Hillyer C. Double recurrence of FSGS after two renal transplants with complete regression after plasmapheresis and ACE inhibitors. Transfus Med Rev 2001. [DOI: 10.1016/s0887-7963(01)80069-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
48
|
Reid ME, Hillyer C, Dzik S, Goldman M. Journal club. Transfus Med Rev 2001. [DOI: 10.1053/tm.2001.24807] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
49
|
Hillyer C. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. Transfus Med Rev 2001. [DOI: 10.1016/s0887-7963(01)80035-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
50
|
Hillyer C. The natural history of hepatitis C virus infection. Transfus Med Rev 2001. [DOI: 10.1016/s0887-7963(01)80044-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|